- Home
- OCX vs INKT Comparison
OCX vs INKT Comparison
Compare OCX & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCX
- INKT
- Stock Information
- Founded
- OCX 2009
- INKT 2017
- Country
- OCX United States
- INKT United States
- Employees
- OCX N/A
- INKT N/A
- Industry
- OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- INKT Medicinal Chemicals and Botanical Products
- Sector
- OCX Health Care
- INKT Health Care
- Exchange
- OCX Nasdaq
- INKT Nasdaq
- Market Cap
- OCX 35.1M
- INKT 36.7M
- IPO Year
- OCX N/A
- INKT 2021
- Fundamental
- Price
- OCX $2.65
- INKT $10.10
- Analyst Decision
- OCX Buy
- INKT Strong Buy
- Analyst Count
- OCX 3
- INKT 2
- Target Price
- OCX $4.42
- INKT $6.50
- AVG Volume (30 Days)
- OCX 87.8K
- INKT 70.0K
- Earning Date
- OCX 04-11-2025
- INKT 03-20-2025
- Dividend Yield
- OCX N/A
- INKT N/A
- EPS Growth
- OCX N/A
- INKT N/A
- EPS
- OCX N/A
- INKT N/A
- Revenue
- OCX $709,000.00
- INKT N/A
- Revenue This Year
- OCX N/A
- INKT N/A
- Revenue Next Year
- OCX $106.34
- INKT N/A
- P/E Ratio
- OCX N/A
- INKT N/A
- Revenue Growth
- OCX N/A
- INKT N/A
- 52 Week Low
- OCX $1.92
- INKT $4.56
- 52 Week High
- OCX $3.48
- INKT $19.00
- Technical
- Relative Strength Index (RSI)
- OCX 64.49
- INKT 54.73
- Support Level
- OCX $2.21
- INKT $8.97
- Resistance Level
- OCX $2.85
- INKT $9.98
- Average True Range (ATR)
- OCX 0.22
- INKT 1.44
- MACD
- OCX 0.07
- INKT -0.07
- Stochastic Oscillator
- OCX 77.90
- INKT 42.97
About OCX Oncocyte Corporation
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.